Geron’s the Biotech of the Day
Geron saw its shares rise $1.72, or 25%, to $8.68 after the company said it has received a patent that could be used in stem-cell research. The process would be used, if it’s ever needed, to provide an additional level of safety for cell therapies made from human embryonic stem cells, the company said.
India ‘to approve GM potato’ The commercial growing of a genetically modified potato which contains nutrients lacking in the diets of many of the poorest is expected to be approved in India within six months.
Genentech’s Next Move
Genentech stunned the cancer world last week with news that its Avastin colon cancer drug extended patients’ lives by five months, proving wrong skeptics who said the blood vessel-blocking drug would never work. Now the biotech pioneer is embarking on a bold strategy to dominate the cancer drug market for decades to come by combining drugs even before they are approved.
This Dutchman Is Flying
Maverick biotech firm Genzyme is winning big profits from a contrarian strategy: Think small
GM crops ‘good for developing countries’ In a discussion paper out on Tuesday to coincide with a national GM debate in the UK, the influential Nuffield Council on Bio-ethics says the technology has the potential to increase crop yields and improve the livelihoods of poor people.
BIOTECH RALLIES The promise of new cancer therapies coming out of last week’s American Society of Clinical Oncology meeting in Chicago has helped restore vigor to the biopharmaceutical industry. It has also gotten a boost from a spate of new product approvals and generally upbeat earnings reports this year.
Financial Snapshot For May 2003: Yee Hah The biotech sector has turned in a remarkable performance this year – especially in May, when the stocks took off like a rocket. And, so far, they’re still climbing…
BIOTECH TEMPERATURE RISES
Investors are showing classic symptoms of biotech fever.
They’re seizing on good news about drug trials, cheering new drug-related news and buying shares contagiously…
Biotech is benign
Europe’s continued blocking of GM imports is illegal, unjustified and founded on ignorance.
Science and Law: Swapping the lab for the law
For scientists who want a career in law, the options are greater than ever – and some don’t even involve going back to school